In a significant advancement for the burgeoning field of preventive medicine, Neko Health has announced the most comprehensive update to its full-body health scanning platform since the company’s inception. By integrating sophisticated body composition analysis and seamless wearable data synchronization, the health-tech innovator is attempting to bridge the gap between reactive medical treatment and proactive, data-driven wellness.
This rollout, currently active across the company’s clinical network, marks a shift toward a more holistic view of metabolic health, moving beyond traditional, often outdated, metrics like Body Mass Index (BMI).
The Core Innovation: Measuring the "Invisible" Risks
At the heart of the update is the introduction of advanced body composition imaging. Utilizing its proprietary, non-invasive imaging hardware, Neko Health can now quantify visceral fat—the adipose tissue stored deep within the abdominal cavity, surrounding vital organs such as the liver, pancreas, and intestines.
Unlike subcutaneous fat, which is stored directly under the skin, visceral fat is metabolically active and highly inflammatory. It is clinically recognized as a primary driver of insulin resistance, Type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease. Historically, identifying high levels of visceral fat required expensive and often radiation-heavy diagnostic imaging, such as CT or MRI scans. Neko Health’s proprietary technology achieves this assessment without the use of X-ray radiation, offering a safe, repeatable, and accessible way for patients to monitor their internal health.
“Our latest advancements are more than new features—they’re a clear signal of what’s next for Neko Health,” said Hjalmar Nilsonne, Founder and CEO of Neko Health. “These features reflect something fundamental about how we operate: we are never finished. Every scan should be more valuable than the last; every visit should tell members something they couldn’t have known otherwise.”
Chronology of Neko Health’s Expansion
Neko Health has moved with remarkable speed since it first emerged from stealth mode. Below is a timeline highlighting the trajectory of the company’s growth and technological development:
- Initial Launch: Neko Health debuted its revolutionary one-hour full-body scan in Stockholm, Sweden, focusing on rapid, data-dense health assessments that include skin, heart, and metabolic markers.
- European Expansion: Following its initial success in Sweden, the company expanded its physical footprint into the United Kingdom, establishing state-of-the-art clinics in London, Manchester, and Birmingham.
- January 2025: A watershed moment for the company, Neko Health successfully closed a $260 million Series B funding round. This massive injection of capital was earmarked specifically for accelerating R&D and scaling the company’s footprint into the competitive US and broader European markets.
- Mid-2026 Update: The current rollout marks the first major feature overhaul, integrating wearable data and advanced visceral fat analysis into the existing clinical framework.
Bridging Clinical Data with Daily Living: Wearable Integration
One of the most significant challenges in modern medicine is the disconnect between "point-in-time" clinical data and the longitudinal reality of a patient’s lifestyle. A patient’s blood pressure, weight, or metabolic markers at a clinic visit may not reflect their typical daily behavior.
Neko Health is addressing this by allowing members to import data from wearables directly into their patient profile. Via the Neko Health App on iOS, users can now synchronize their Apple Health data, which aggregates metrics such as:
- Step count and activity levels: Providing a proxy for physical activity intensity.
- Sleep patterns: Crucial for assessing metabolic health and stress recovery.
- Heart Rate Variability (HRV): A key indicator of autonomic nervous system health and physiological stress.
By importing these metrics, Neko clinicians can review a patient’s health scan within the context of their lifestyle. For instance, a rise in visceral fat over a year can now be cross-referenced with shifts in sleep quality or physical activity, allowing for highly tailored, actionable advice rather than generalized wellness tips.
Implications for the Healthcare Landscape
The move by Neko Health signals a broader transition in the medical device and diagnostic industry. For decades, the medical model has been designed for acute care—treating patients once they are already symptomatic. Neko’s model represents "Medicine 3.0," a paradigm focused on early detection and the optimization of health span.
1. The Death of BMI
The healthcare industry has long acknowledged that BMI is a flawed metric. It does not distinguish between muscle mass and fat, nor does it account for fat distribution. By providing visceral fat percentages, Neko Health is pushing the medical establishment to adopt more precise, data-rich diagnostic markers.
2. Longitudinal Health Tracking
One of the most powerful features of the update is the ability to track health changes over time. Because Neko Health’s scans are non-invasive and radiation-free, they can be performed annually or biannually. This creates a longitudinal data set that can show "year-to-year changes," allowing clinicians to see the trajectory of a patient’s health before a disease manifests clinically.
3. Democratization of High-End Diagnostics
Previously, the level of insight provided by a Neko Health scan—measuring body fat distribution and internal organ health—was reserved for high-end research studies or elite athletic programs. By developing its technology, software, and clinical protocols in-house, Neko is effectively democratizing access to high-fidelity diagnostic tools.
Official Responses and Strategic Vision
The $260 million investment secured in 2025 has clearly been put to work. By focusing on vertical integration—owning the scanner hardware, the software analysis, and the clinical delivery—Neko is avoiding the pitfalls of fragmented healthcare systems.
CEO Hjalmar Nilsonne’s philosophy centers on the idea of a "living" system. By redesigning the healthcare system from the ground up, the company aims to move away from the "one-size-fits-all" approach that currently plagues primary care. Instead, they offer a model where the patient is the owner of their data, and the clinician serves as an analyst and guide, empowered by a constant stream of new metrics.
Future Outlook
As Neko Health looks toward the US market, the integration of wearable data and body composition analysis will likely serve as a blueprint for other health-tech firms. The challenge ahead will be scalability. While the company currently operates in a handful of major European hubs, the integration of wearable data requires robust data privacy and cybersecurity protocols to ensure that sensitive health information is handled with the highest level of security.
Furthermore, the company must continue to prove the clinical validity of its metrics to the broader medical community. By providing clinicians with the necessary context to offer "tailored guidance," Neko is not just selling a scan; they are selling a new relationship between patients and their own biological data.
In conclusion, Neko Health’s latest update represents a meaningful step toward a future where healthcare is proactive, precise, and deeply personal. By moving beyond the surface-level metrics that have defined health assessments for decades, the company is equipping both patients and doctors with the tools needed to intervene before a health issue becomes a medical crisis. As the company continues to innovate and expand its global footprint, the impact of its diagnostic technology on metabolic health outcomes will be closely watched by the industry and the public alike.
About the Author
